GRAIL to Announce Second Quarter 2025 Financial Results
GRAIL (Nasdaq: GRAL), a healthcare company focused on early cancer detection, will release its Q2 2025 financial results on Tuesday, August 12, 2025 after market close. Management will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss the results and business progress.
Interested parties can access the live webcast through GRAIL's investor relations website at investors.grail.com. Participants are advised to register at least ten minutes before the call's scheduled start time through the provided registration link.
GRAIL (Nasdaq: GRAL), un'azienda sanitaria specializzata nella diagnosi precoce del cancro, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 il martedì 12 agosto 2025 dopo la chiusura del mercato. La direzione terrà una conference call e una webcast alle 13:30 PT / 16:30 ET per discutere i risultati e i progressi aziendali.
Gli interessati possono seguire la diretta webcast attraverso il sito web per gli investitori di GRAIL all'indirizzo investors.grail.com. Si consiglia ai partecipanti di registrarsi almeno dieci minuti prima dell'orario previsto per l'inizio della chiamata tramite il link di registrazione fornito.
GRAIL (Nasdaq: GRAL), una empresa del sector salud enfocada en la detección temprana del cáncer, publicará sus resultados financieros del segundo trimestre de 2025 el martes 12 de agosto de 2025 después del cierre del mercado. La dirección llevará a cabo una llamada de conferencia y una transmisión en vivo a las 1:30 PM PT / 4:30 PM ET para analizar los resultados y el progreso del negocio.
Los interesados pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas de GRAIL en investors.grail.com. Se recomienda a los participantes registrarse al menos diez minutos antes del inicio programado de la llamada mediante el enlace de registro proporcionado.
GRAIL (나스닥: GRAL)은 조기 암 진단에 중점을 둔 헬스케어 기업으로, 2025년 2분기 재무 결과를 2025년 8월 12일 화요일 시장 마감 후 발표할 예정입니다. 경영진은 오후 1:30 PT / 오후 4:30 ET에 컨퍼런스 콜 및 웹캐스트를 진행하여 결과와 사업 진행 상황을 논의할 예정입니다.
관심 있는 분들은 GRAIL 투자자 관계 웹사이트 investors.grail.com을 통해 라이브 웹캐스트에 접속할 수 있습니다. 참가자는 제공된 등록 링크를 통해 콜 시작 예정 시간 최소 10분 전에 등록하는 것이 권장됩니다.
GRAIL (Nasdaq : GRAL), une entreprise de santé spécialisée dans la détection précoce du cancer, publiera ses résultats financiers du deuxième trimestre 2025 le mardi 12 août 2025 après la clôture du marché. La direction tiendra une conférence téléphonique et un webcast à 13h30 PT / 16h30 ET pour discuter des résultats et des avancées de l'entreprise.
Les personnes intéressées peuvent accéder au webcast en direct via le site des relations investisseurs de GRAIL à l'adresse investors.grail.com. Il est conseillé aux participants de s'inscrire au moins dix minutes avant l'heure prévue du début de l'appel via le lien d'inscription fourni.
GRAIL (Nasdaq: GRAL), ein Gesundheitsunternehmen mit Schwerpunkt auf der Früherkennung von Krebs, wird seine Finanzergebnisse für das zweite Quartal 2025 am Dienstag, den 12. August 2025 nach Börsenschluss veröffentlichen. Das Management wird um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz und Webcast abhalten, um die Ergebnisse und den Geschäftsfortschritt zu besprechen.
Interessierte können den Live-Webcast über die Investor-Relations-Website von GRAIL unter investors.grail.com verfolgen. Teilnehmer werden gebeten, sich mindestens zehn Minuten vor dem geplanten Beginn der Telefonkonferenz über den bereitgestellten Registrierungslink anzumelden.
- None.
- None.
Second Quarter 2025 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.
Please register for the live event at https://grail-q2-financial-results-2025.open-exchange.net/.
To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-second-quarter-2025-financial-results-302516336.html
SOURCE GRAIL, Inc.
FAQ
When will GRAIL (GRAL) release Q2 2025 earnings?
What time is GRAIL's Q2 2025 earnings call?
How can I access GRAIL's Q2 2025 earnings call?
What is GRAIL's main business focus?
